Russia Develops New Cancer Vaccine 

The Russian Health Ministry has announced that it has developed a cancer vaccine that will be distributed to patients free of charge in early 2025. The vaccine will reportedly be used to treat cancer patients rather than given to the public to prevent cancer.

Andrey Kaprin, the General Director of the Radiology Medical Research Centre of the Russian Ministry of Health, announced that the country has developed its own mRNA vaccine against cancer and it would be distributed to people free of charge, reported Russia’s TASS news agency.

Previously, Alexander Gintsburg, Director of the Gamaleya National Research Centre for Epidemiology and Microbiology, shared with TASS that pre-clinical trials showed the vaccine can suppress tumor growth and prevent potential metastases.

"The vaccine’s pre-clinical trials had shown that it suppresses tumor development and potential metastases," Andrey Kaprin told TASS.

An mRNA vaccine uses a small fragment of messenger RNA (a molecule that carries specific instructions from DNA) to instruct the body's cells to produce a specific protein associated with cancer cells. This triggers the immune system to recognise and attack those cancer cells, effectively teaching the body to target the disease.

Unlike traditional vaccines, which often use weakened or inactivated pathogens, mRNA vaccines leverage the body's own cellular machinery to create a precise immune response tailored to the cancer being treated.